Park Medi World Q4 FY26: Profit up 58%, revenue 30%

What Park Medi World reported for the March quarter

Park Medi World Ltd reported a strong set of consolidated numbers for the March quarter (Q4 FY26), led by higher revenue from operations. The company said consolidated net profit rose 58% year-on-year to Rs 71 crore for the quarter. In the same quarter last year, consolidated net profit stood at Rs 45 crore. Consolidated revenue from operations increased 30% to Rs 460.4 crore, compared with Rs 354 crore a year earlier. The figures were disclosed through an exchange filing referenced in the report.

Profit and revenue growth, with a note on reported variations

Alongside the exchange-filing figures, another performance note in the provided text cited slightly different Q4 FY26 profitability. That note stated EBITDA rose 44% to Rs 127.4 crore and EBITDA margin improved to 27.7%. It also reported Q4 net profit at Rs 76.8 crore, with net profit margin at 16.7%. These numbers are presented as stated in the source text, even though they differ from the Rs 71 crore profit figure cited from the exchange filing. Investors typically track the company’s final filed results for consistency across disclosures.

Full-year FY26 performance

For FY26, Park Medi World reported consolidated revenue from operations of Rs 1,679.4 crore and consolidated net profit of Rs 273.6 crore. The company had posted a net profit of Rs 215.4 crore in FY25, indicating an improvement in annual profitability. The same note in the text described FY26 as the company’s best annual performance so far, with revenue up 21% year-on-year to Rs 1,679.4 crore. It also listed FY26 EBITDA at Rs 444.3 crore, up 20%, with EBITDA margin at 26.5%. Net profit margin for FY26 was reported at 16.3%.

Cash flow and working capital indicators

Operational cash flow was reported at Rs 32.91 crore (converted from Rs 329.1 million) in the provided note. The company also reported improvement in collections, reflected in debtor days declining to 129 days from 161 days. These metrics matter for hospital operators because working capital can be stretched by insurer and corporate payment cycles. A reduction in debtor days can support liquidity and reduce the need for short-term borrowing. The disclosure also indicates a focus on receivables management alongside growth.

Stock market reaction after the results

Despite the earnings announcement and an intra-day rise of nearly 4%, Park Medi World shares ended lower. The report said the stock settled 4.61% down at Rs 247.82 per share on the BSE. A repeated line also stated the same closing move on the NSE at Rs 247.82 after a similar intra-day rise. In the Hindi market update, the stock was reported around mid-afternoon at Rs 246.29 on the NSE (down 5.20%) and Rs 246.50 on the BSE (down 4.95%). The mixed pattern suggests that traders reacted to the results but later booked profits, leading to a weaker close.

Key reported financial metrics at a glance

How Q3 and 9M FY26 numbers frame the Q4 print

The provided text also included operating updates for earlier periods in FY26. Park Medi World reported Q3 FY26 revenue of Rs 410 crore, described as an 18% year-on-year increase. For the nine-month period (9M FY26), revenue was reported at Rs 1,218.9 crore, up 17% year-on-year. Profit after tax (PAT) for 9M FY26 was reported at Rs 196.8 crore, up 43%, with a net margin of 16%. Q3 FY26 PAT was stated at Rs 52.8 crore, up 16%, with a PAT margin of 12.89%.

Market impact: what investors can take away

From the reported numbers, the key positive signal is the combination of revenue growth and higher profitability in Q4 and FY26. Margins were also reported to have improved in the quarter and over the year, with EBITDA margin at 27.7% in Q4 and 26.5% for FY26 in the cited note. Improved debtor days and disclosed operating cash flow add context on working-capital discipline. But the share price finishing lower, despite a higher intra-day move, shows that the market reaction was not purely directional on headline growth. In hospital stocks, investors often weigh growth rates, margins, and cash conversion alongside expectations already priced into the stock.

Why this result matters for the hospital sector narrative

Hospital operators typically face a mix of occupancy dynamics, case mix changes, and payer-led billing cycles that influence both margins and cash flow. A quarter with 30% revenue growth and a materially higher profit base can signal stronger operating leverage, particularly when margins are rising. At the same time, the presence of multiple profit figures in the provided text highlights why investors look closely at the final consolidated statements and consistent definitions of profit and EBITDA. For Park Medi World, FY26 totals provide a clearer annual view: Rs 1,679.4 crore revenue and Rs 273.6 crore net profit.

Conclusion

Park Medi World’s Q4 FY26 update showed faster revenue growth and a sharp rise in quarterly profit, while FY26 profit also improved versus FY25. The stock, however, closed lower after an intra-day rise, indicating a more cautious near-term trading response. Investors will watch for the company’s next quarterly update and any further disclosures that reconcile differences across reported profit figures and operational metrics.